PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 153 filers reported holding PDL BIOPHARMA INC in Q4 2018. The put-call ratio across all filers is 0.59 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $4,074,000 | +82.0% | 1,293,289 | +68.2% | 0.01% | +50.0% |
| Q2 2020 | $2,238,000 | +4661.7% | 769,081 | +4533.0% | 0.00% | – |
| Q1 2020 | $47,000 | -92.5% | 16,600 | -91.4% | 0.00% | -100.0% |
| Q4 2019 | $630,000 | -26.9% | 194,000 | -51.4% | 0.00% | -50.0% |
| Q3 2019 | $862,000 | -85.0% | 398,950 | -78.1% | 0.00% | -84.6% |
| Q2 2019 | $5,732,000 | -40.1% | 1,825,381 | -29.1% | 0.01% | -43.5% |
| Q1 2019 | $9,576,000 | +2716.5% | 2,574,283 | +2098.3% | 0.02% | +2200.0% |
| Q4 2018 | $340,000 | +14.1% | 117,105 | -10.7% | 0.00% | 0.0% |
| Q1 2017 | $298,000 | – | 131,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nine Chapters Capital Management LLC | 119,700 | $254,000 | 0.43% |
| GSA CAPITAL PARTNERS LLP | 1,587,756 | $3,366,000 | 0.20% |
| AMERICAFIRST CAPITAL MANAGEMENT, LLC | 60,901 | $129,110,000 | 0.14% |
| Acrospire Investment Management LLC | 129,480 | $274,000 | 0.11% |
| SECOR Capital Advisors, LP | 410,323 | $870,000 | 0.11% |
| RBF Capital, LLC | 251,421 | $540,000 | 0.08% |
| Park West Asset Management LLC | 400,000 | $848,000 | 0.07% |
| MACKENZIE FINANCIAL CORP | 4,687,825 | $9,938,000 | 0.06% |
| CIGNA INVESTMENTS INC /NEW | 261,533 | $554,000,000 | 0.06% |
| ACADIAN ASSET MANAGEMENT LLC | 5,503,285 | $11,665,000 | 0.06% |